Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.
BACKGROUND
The accumulation of protease resistant conformers of the prion protein (PrP(res)) is a key pathological feature of prion diseases. Polyanions, including RNA and glycosaminoglycans have been identified as factors that contribute to the propagation, transmission and pathogenesis of prion disease. Recent studies have suggested that the contribution of these cofactors to prion propagation may be species specific.


RESULTS
In this study a cell-free assay was used to investigate the molecular basis of polyanion stimulated PrP(res) formation using brain tissue or cell line derived murine PrP. Enzymatic depletion of endogenous nucleic acids or heparan sulphate (HS) from the PrP(C) substrate was found to specifically prevent PrP(res) formation seeded by mouse derived PrP(Sc). Modification of the negative charge afforded by the sulphation of glycosaminoglycans increased the ability of a familial PrP mutant to act as a substrate for PrP(res) formation, while having no effect on PrP(res) formed by wildtype PrP. This difference may be due to the observed differences in the binding of wild type and mutant PrP for glycosaminoglycans.


CONCLUSIONS
Cofactor requirements for PrP(res) formation are host species and prion strain specific and affected by disease associated mutations of the prion protein. This may explain both species and strain dependent propagation characteristics and provide insights into the underlying mechanisms of familial prion disease. It further highlights the challenge of designing effective therapeutics against a disease which effects a range of mammalian species, caused by range of aetiologies and prion strains.
Lawson
Victoria A
VA
Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia. vlawson@unimelb.edu.au
Lumicisi
Brooke
B
Welton
Jeremy
J
Machalek
Dorothy
D
Gouramanis
Katrina
K
Klemm
Helen M
HM
Stewart
James D
JD
Masters
Colin L
CL
Hoke
David E
DE
Collins
Steven J
SJ
Hill
Andrew F
AF
D000818:Animals; D002460:Cell Line; D002474:Cell-Free System; D006025:Glycosaminoglycans / Q000378:metabolism*; D006497:Heparan Sulfate / Q000378:metabolism; D051379:Mice; D050505:Mutant Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D009696:Nucleic Acids / Q000378:metabolism; D017096:Prion Diseases / Q000235:genetics / Q000378:metabolism; D011328:Prions / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D017510:Protein Folding; D055672:Static Electricity; D013431:Sulfates / Q000378:metabolism*
D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D050505:Mutant Proteins; D009696:Nucleic Acids; D011328:Prions; D013431:Sulfates
Brain Res Bull. 2006 Jan 30;68(5):346-54
16377442
Cell. 2005 Apr 22;121(2):195-206
15851027
Ann Neurol. 1979 Jun;5(6):581-4
382976
J Mol Biol. 2004 Nov 26;344(3):827-37
15533448
J Pathol. 2007 Apr;211(5):582-590
17334982
J Biol Chem. 2005 Apr 29;280(17):17062-7
15668247
Biochem Biophys Res Commun. 1986 Dec 15;141(2):870-7
3026396
Science. 2004 Jul 30;305(5684):673-6
15286374
J Recept Signal Transduct Res. 2008;28(3):153-61
18569523
J Mol Biol. 2001 Apr 6;307(4):1011-21
11286552
J Mol Biol. 2010 Jan 22;395(3):475-90
19913031
Arch Virol Suppl. 2000;(16):95-102
11214938
Biochem Biophys Res Commun. 2004 Jan 16;313(3):559-67
14697227
Nature. 1994 Aug 11;370(6489):471-4
7913989
Lancet. 2004 Jan 3;363(9402):51-61
14723996
Biochem Soc Symp. 2005;(72):211-22
15649144
C R Biol. 2002 Jan;325(1):17-23
11862616
Science. 2010 Feb 26;327(5969):1132-5
20110469
J Gen Virol. 2008 Jan;89(Pt 1):341-347
18089759
EMBO J. 2001 Feb 1;20(3):377-86
11157745
Lab Invest. 1990 Nov;63(5):601-11
1977959
Biochemistry. 2001 Jun 12;40(23):6982-7
11389614
Biochemistry. 2003 Mar 25;42(11):3295-304
12641461
J Mol Biol. 2002 Sep 6;322(1):153-61
12215421
J Biol Chem. 2004 Sep 24;279(39):40788-94
15262998
Nature. 2001 Jun 14;411(6839):810-3
11459061
Nature. 2006 Oct 19;443(7113):803-10
17051207
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7546-51
17456603
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4055-9
11259656
Biochemistry. 2010 May 11;49(18):3928-34
20377181
J Mol Biol. 2003 Sep 5;332(1):47-57
12946346
J Pathol Bacteriol. 1968 Apr;95(2):377-81
4297026
Arch Biochem Biophys. 1999 Oct 15;370(2):250-7
10510284
J Recept Signal Transduct Res. 2007;27(5-6):433-43
18097941
Protein Sci. 2006 Mar;15(3):609-19
16452616
J Virol. 2004 May;78(10):4999-5006
15113880
J Biol Chem. 1995 Dec 15;270(50):30221-9
8530433
Acta Neuropathol. 1989;77(4):337-42
2523631
J Gen Virol. 2003 Sep;84(Pt 9):2595-2603
12917481
J Biol Chem. 2002 May 24;277(21):18421-30
11882649
J Mol Biol. 2002 May 31;319(2):527-40
12051926
J Biol Chem. 2005 Jul 22;280(29):26873-9
15917229
Biochemistry. 2003 Apr 15;42(14):4127-35
12680767
J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):733-4
17314188
J Biol Chem. 1996 Jan 19;271(3):1633-7
8576163
J Cell Physiol. 1993 Nov;157(2):319-25
7901226
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9551-2
17535888
J Biol Chem. 2005 Apr 29;280(17):17057-61
15668233
J Gen Virol. 2007 Oct;88(Pt 10):2905-2914
17872546
J Mol Biol. 2002 Feb 1;315(5):1241-56
11827491
Chembiochem. 2002 Aug 2;3(8):717-25
12203970
EMBO J. 1996 Mar 15;15(6):1255-64
8635458
J Biol Chem. 2003 Oct 10;278(41):40041-9
12871949
J Biol Chem. 2010 May 7;285(19):14083-7
20304915
Cell. 1993 Jul 2;73(7):1339-47
8100741
J Virol. 2007 Oct;81(19):10786-91
17626095
Biochemistry. 1999 Mar 16;38(11):3280-4
10079070
Eur J Neurol. 2008 May;15(5):458-64
18355301
Science. 1982 Apr 9;216(4542):136-44
6801762
J Biol Chem. 1999 Dec 17;274(51):36267-73
10593915
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11667-72
9751723
J Recept Signal Transduct Res. 2007;27(5-6):411-31
18097940
Nature. 2003 Oct 16;425(6959):717-20
14562104
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9741-6
17535913
Int J Biochem Cell Biol. 2008;40(12):2793-801
18590830
J Biol Chem. 1998 Nov 20;273(47):31048-52
9813003
J Biol Chem. 2001 Jun 1;276(22):19301-9
11278562